Cite
HARVARD Citation
Axelsen, M. et al. (2015). A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial. Annals of the rheumatic diseases. 74 (5), pp. 867-875. [Online].